Carl Byrnes

Stock Analyst at Northland Capital Markets

(0.79)
# 2,910
Out of 4,479 analysts
14
Total ratings
44.44%
Success rate
-5.88%
Average return

9 Stocks

Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.21
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $2$1.25
Current: $0.71
Upside: +77.30%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $8
Current: $0.54
Upside: +1,380.11%
BrainsWay
Nov 17, 2022
Maintains: Outperform
Price Target: $15$5
Current: $5.92
Upside: -15.54%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60$80
Current: $18.28
Upside: +337.64%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.78
Upside: -
Esperion Therapeutics
May 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $2.34
Upside: -
Aytu BioPharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.86
Upside: -
Heron Therapeutics
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $2.74
Upside: -